HOME ·

01177.HK

Sino Biopharmaceutical (01177.HK): TRD205 (AT2R Antagonist) Included in CDE’s Breakthrough Therapy Designation List
Tags：
Sino Biopharmaceutical01177.HK
2026-07-14
SBP GROUP (01177.HK): NDA Accepted for Category 1 Innovative Drug IDH1 Inhibitor TQB3454 for Advanced Biliary Tract Cancer
Tags：
SBP GROUP01177.HKNew Drug Application
2026-07-10
SINO BIOPHARM(01177.HK): Deepens Exclusive Strategic Cooperation with GSK, Secures Commercialisation Rights for Two Core Innovative Respiratory Drugs
Tags：
SINO BIOPHARM01177.HKGSKcooperation
2026-07-08
SINO BIOPHARM(01177.HK): Exclusive Licensing Agreement with AstraZeneca for TQC3721, USD200 Million Upfront Payment plus Up to USD1.9 Billion Milestones
Tags：
SINO BIOPHARM01177.HKAstraZenecacooperation
2026-07-08
SINO BIOPHARM(01177.HK): NDA for Class 2.2 New Drug Ropivacaine Hydrochloride Sustained-Release Solution Accepted, Indicated for Long-Acting Postoperative Analgesia
Tags：
SINO BIOPHARM01177.HKNew Drug Application
2026-07-03
SINO BIOPHARM (01177.HK): NDA for CLDN18.2 ADC Tecotabart Vedotin Accepted for Gastric Cancer Treatment
Tags：
SINO BIOPHARM01177.HKNew Drug Application
2026-06-23
SINO BIOPHARM(01177.HK): Class 1 Innovative Drug Pelecanam Spray (Puyike®) Approved by NMPA for Secondary Wound Infection Caused by Burns and Scalds
Tags：
SINO BIOPHARM01177.HKClinical Trial
2026-06-23
Sino Biopharmaceutical Limited (01177.HK): Appointment of Dr. Chen Lieping and Dr. Lu Bai as Independent Non-executive Directors
Tags：
Sino Biopharmaceutical Limited01177.HK
2026-06-17
SINO BIOPHARM (01177.HK): Subsidiary Chia Tai Tianqing Enters Exclusive Strategic Partnership with GSK to Accelerate China Launch of Hepatitis B Innovative Drug Bepirovirsen
Tags：
SINO BIOPHARM01177.HKGSKChia Tai Tianqingstrategic cooperation
2026-05-11
SBP GROUP(01177.HK) will spend HKD 10.05 million to repurchase 1.86 million shares on May 8, 2026
Tags：
SBP GROUP01177.HK
2026-05-09
SBP GROUP(01177.HK) will spend HKD 10.05 million to repurchase 1.85 million shares on May 7, 2026
Tags：
SBP GROUP01177.HK
2026-05-07
SBP GROUP(01177.HK) will spend HKD 10.01 million to repurchase 1.83 million shares on Apr 29, 2026
Tags：
SBP GROUP01177.HKrepurchase
2026-04-29
SBP GROUP(01177.HK) will spend HKD 10.05 million to repurchase 1.81 million shares on Apr 27, 2026
Tags：
SBP GROUP01177.HKrepurchase
2026-04-27
SBP GROUP(01177.HK) will spend HKD 10.09 million to repurchase 1.78 million shares on Apr 24, 2026
Tags：
SBP GROUP01177.HK
2026-04-24
SBP GROUP(01177.HK) will spend HKD 10.05 million to repurchase 1.8 million shares on Apr 23, 2026
Tags：
SBP GROUP01177.HKrepurchase
2026-04-23
SBP GROUP(01177.HK) will spend HKD 10.02 million to repurchase 1.72 million shares on Apr 22, 2026
Tags：
SBP GROUP01177.HKrepurchase
2026-04-22
SBP GROUP(01177.HK) will spend HKD 10.06 million to repurchase 1.73 million shares on Apr 21, 2026
Tags：
SBP GROUP01177.HK
2026-04-21